In its judgment of 16 April 2015 in Joined Cases C-317/13 and C-679/13 [Judgment of the Court of Justice of 16 April 2015, Parliament v Council, Joined Cases C-317/13 and C-679/13, ECLI:EU:C:2015:223.], the Court of Justice of the European Union held that prior to adopting an implementing decision on the basis of Article 8(3) of Decision 2005/387/JHA, the Council should consult the European Parliament. Council Implementing Decision 2014/688/EU [Council Implementing Decision 2014/688/EU of 25 September 2014 on subjecting 4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25I-NBOMe), 3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide (AH-7921), 3,4-methylenedioxypyrovalerone (MDPV) and 2-(3-methoxyphenyl)-2(ethylamino)cyclohexanone (methoxetamine) to control measures (OJ L 287, 1.10.2014, p. 22).] was adopted without such prior consultation and consequently is vitiated by a procedural defect. Decision 2014/688/EU should, therefore, be replaced by this Decision.
Recital 34, Decision_act (EU) 2015/1875
In forcecited 1×
Judgment of the Court (Third Chamber) of 23 December 2015. European Parliament v Council of the European Union.Decision
Recitals 34 and 35 in the preamble to Council Implementing Decision (EU) 2015/1875 of 8 October 2015 on subjecting 4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25I-NBOMe), …
23 Dec 2015 · 62014CJ0595
Judgment of the Court (Fourth Chamber) of 16 April 2015. European Parliament v Council of the European Union.Decision
16 Apr 2015 · 62013CJ0317
- celex=32005D0387
- celex=32014D0688
- ecli=ECLI:ES:C:2015:223
- num:eu=2014/688